Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · IEX Real-Time Price · USD

1.240

+0.010 (0.81%)

At close: Apr 19, 2024, 4:00 PM

1.220

-0.020 (-1.61%)

After-hours: Apr 19, 2024, 5:56 PM EDT

Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	39.88	45.28	27.35	22.06	35.94	57.02	20.2	30.17	9.85	10.76	Upgrade
Short-Term Investments	79.23	172.29	164.07	32.07	39.08	110.95	173.66	107.05	75.02	5.37	Upgrade
Cash & Cash Equivalents	119.11	217.57	191.41	54.13	75.02	167.97	193.86	137.22	84.87	16.13	Upgrade
Cash Growth	-45.26%	13.67%	253.61%	-27.84%	-55.34%	-13.35%	41.27%	61.69%	426.15%	21.06%	Upgrade
Receivables	0.3	0.48	0.62	0.77	0.7	0.56	0.48	0	0	0	Upgrade
Other Current Assets	9.45	13.5	13	2.59	8.08	10.96	5.88	1.33	1.66	0.2	Upgrade
Total Current Assets	128.86	231.55	205.03	57.49	83.8	179.5	200.22	138.56	86.52	16.33	Upgrade
Property, Plant & Equipment	1.62	1.1	1.34	1.65	2.47	2.29	2.16	0.48	0.36	0.52	Upgrade
Long-Term Investments	62.77	12.24	34.24	0	0	0	15	36.91	7.17	0.52	Upgrade
Goodwill and Intangibles	0.27	6.97	7.05	7.12	7.2	25.78	25.85	0	0	0	Upgrade
Other Long-Term Assets	3.89	2.73	3.55	4.51	4.83	68	0.28	0.14	0.02	0.01	Upgrade
Total Long-Term Assets	68.55	23.05	46.18	13.29	14.49	96.07	43.29	37.53	7.55	1.04	Upgrade
Total Assets	197.41	254.6	251.21	70.78	98.3	275.57	243.51	176.09	94.08	17.38	Upgrade
Accounts Payable	8.88	10.35	9.99	5.25	9.92	11.68	7.82	2.85	0.81	1.26	Upgrade
Current Debt	0.43	0.68	0.69	0.6	0.64	0.14	0	0	0	0	Upgrade
Other Current Liabilities	21.65	10.9	12.25	9.02	11.88	15.53	4.94	3.38	0.75	0.19	Upgrade
Total Current Liabilities	30.95	21.94	22.93	14.87	22.43	27.34	12.76	6.22	1.56	1.45	Upgrade
Long-Term Debt	0	0	0	10.65	0	29.91	0	0	0	0	Upgrade
Other Long-Term Liabilities	9.27	35.04	30.94	7.61	5.95	3.19	5.49	0.37	0	0	Upgrade
Total Long-Term Liabilities	9.27	35.04	30.94	18.26	5.95	33.1	5.49	0.37	0	0	Upgrade
Total Liabilities	40.23	56.98	53.87	33.13	28.39	60.44	18.25	6.6	1.56	1.46	Upgrade
Total Debt	0.43	0.68	0.69	11.26	0.64	30.06	0	0	0	0	Upgrade
Debt Growth	-37.72%	-1.30%	-93.84%	1667.03%	-97.88%	-	-	-	-	-	Upgrade
Retained Earnings	-770.8	-682.32	-595.41	-504.54	-453.53	-292.17	-159.44	-90.91	-42.83	-20.75	Upgrade
Comprehensive Income	-0.11	-0.9	-0.22	-0.09	-0.07	-0.07	-0.25	-0.27	-0.15	-0.01	Upgrade
Shareholders' Equity	157.18	197.62	197.34	37.65	69.91	215.12	225.26	169.49	92.52	-20.76	Upgrade
Net Cash / Debt	118.68	216.89	190.72	42.88	74.38	137.92	193.86	137.22	84.87	16.13	Upgrade
Net Cash / Debt Growth	-45.28%	13.72%	344.83%	-42.36%	-46.07%	-28.86%	41.27%	61.69%	426.15%	21.06%	Upgrade
Net Cash Per Share	1.70	3.33	3.36	1.01	1.80	4.19	6.90	6.41	13.90	9.38	Upgrade
Working Capital	97.9	209.61	182.1	42.62	61.37	152.16	187.46	132.33	84.97	14.88	Upgrade
Book Value Per Share	2.25	3.03	3.48	0.89	1.69	6.54	8.02	7.91	15.15	-12.07	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).